University Of Exeter

The University of Exeter is a public research university located in Exeter, England that receives federal contract and grant awards from various U.S. government agencies. As a higher education institution, it provides research and scientific expertise across multiple disciplines to support federal programs related to health, defense, and scientific advancement. The university collaborates with U.S. agencies and other institutions to conduct studies, develop technologies, and contribute specialized knowledge in areas such as neuroscience, climate science, genetics, and data analysis. Through its partnerships with American universities and research centers, the University of Exeter leverages its academic resources and capabilities to advance scientific understanding and address complex challenges of interest to the U.S. government.

Through federal contracts, the University of Exeter has provided clinical evaluation services for Alzheimer's disease and traumatic brain injury treatments to the National Institute on Aging. This includes conducting clinical trials, performing brain imaging, cognitive assessments, and analyzing biomarkers for investigational drugs like extended-release Phenserine tartrate tablets. The university also received a contract from the Defense Advanced Research Projects Agency to detect early warning signals of climate tipping points, leveraging its expertise in climate science. Additionally, Exeter has supported epidemiology and statistical analysis projects for the National Institute on Aging, analyzing large-scale biobank data to study factors related to neurodegenerative diseases. These contracts have been awarded directly to the university without set-aside designations. The University of Exeter has also served as a subcontractor on defense-related projects, such as collaborating with Peraton Labs to develop business workflow representations and vulnerability identification methods.

Federal grant awards to the University of Exeter have funded a diverse range of research initiatives. The Office of Naval Research has supported work on spin biology and quantum control. The university has received multiple grants from the National Institute on Aging for studies on Alzheimer's disease, including research on psychosis mechanisms, genetic risk factors, and potential treatments. Other grant-funded projects include research on gestational duration and birth weight for the National Institute of Child Health and Human Development, studies on social modifiers of aging for the National Institute on Aging, and investigations of weather phenomena impacts on precipitation for the Department of Energy. Exeter frequently collaborates as a subrecipient with other institutions like Arizona State University, Yale University, and Baylor College of Medicine on these grant-funded studies. The university's expertise in genetics and data analysis has been utilized in projects examining monogenic diabetes, obesity-related neural pathways, and the integration of genomic data to understand pregnancy outcomes.

The University of Exeter holds a single-award indefinite delivery contract with the National Institute on Aging valued at $1,988,692. This IDV, awarded in February 2024, enables the agency to issue task orders for clinical evaluation services related to Alzheimer's disease and traumatic brain injury research over a 30-month period. Specifically, the university can be tasked to conduct clinical trials, perform brain imaging and cognitive assessments, and analyze biomarkers to evaluate the pharmacology of investigational treatments like extended-release Phenserine tartrate tablets. This IDV allows the National Institute on Aging to efficiently access Exeter's expertise in neurodegenerative disease research to support its mission of understanding and addressing conditions affecting aging populations.